Tiger Brokers

HK StockDetailed Quotes
Provided by Tiger Fintech (Singapore) Pte. Ltd.

INNOVENT BIO

96.850
+6.2006.84%
Volume:26.71M
Turnover:2.54B
Market Cap:165.90B
PE:-1.51K
High:98.450
Open:91.900
Low:89.700
Close:90.650
52wk High:106.000
52wk Low:28.650
Shares:1.71B
HK Float Shares:1.71B
Volume Ratio:1.08
T/O Rate:1.56%
Dividend:- -
Dividend Rate:- -
EPS(LYR):-0.064
ROE:8.43%
ROA:3.44%
PB:10.45
PE(LYR):-1,512.95
PS:13.19

Loading ...

OverviewCompanyNewsFilings

Company Profile

Company Name:
INNOVENT BIO
Exchange:
SEHK
Establishment Date:
2011
Employees:
6190
Office Location:
168 Dongping Street,Suzhou Industrial Park,Suzhou,Jiangsu Province,China
Website:
http://www.innoventbio.com
Zip Code:
215123
Phone:
86 512 6956 6088
Fax:
86 512 6956 6088
Introduction:
Innovent Biologics Inc is an investment holding company principally engaged in the research, development, production and sale of innovative medicines for the treatment of diseases such as cancer, cardiovascular and metabolic (CVM), autoimmune and eye diseases. The pipeline covering monoclonal antibodies, multi-specific antibodies, immuno-cytokine, antibody-drug conjugates (ADCs), cell therapy and small molecules. The Company’s main products include TYVYT (sintilimab injection), BYVASDA (bevacizumab injection), SULINNO (adalimumab injection), HALPRYZA (rituximab injection), Pemazyre (pemigatinib) and others. The Company mainly operates in the domestic and overseas markets.

Directors

Name
Position
DE-CHAO MICHAEL YU
Chairman of the Board,Executive Director,Chairman of the Strategic and Development Committee,Member of the Nomination Committee
EDE, Ronald Hao Xi
Executive Director,Member of the Strategic and Development Committee
ZHANG Qian
Executive Director,Member of the Strategic and Development Committee
Charles L. Cooney
Independent Director,Member of the Strategic and Development Committee,Member of the Nomination Committee,Audit Committee Member
XU Yi Yin
Independent Director,Chairman of the Remuneration and Assessment Committee,Member of the Nomination Committee,Audit Committee Chairman
Gary J. Zieziula
Independent Director,Member of the Strategic and Development Committee,Member of the Remuneration and Assessment Committee,Audit Committee Member
LU Shun
Independent Director,Member of the Strategic and Development Committee
CHEN Shu Yun
Independent Director,Independent Director,Member of the Strategic and Development Committee,Member of the Remuneration and Assessment Committee,Chairman of the Nomination Committee,Audit Committee Member
Stephen A. Sherwin
Independent Director,Member of the Strategic and Development Committee

Shareholders

Name
Position
DE-CHAO MICHAEL YU
CEO
YOU Fei
CFO
WANG Yan Ju
Corporate Secretary
CHEN Luo Er
Corporate Secretary